Diabetes Mellitus and Outcomes of Cardiac Resynchronization With Implantable Cardioverter-Defibrillator Therapy in Older Patients With Heart Failure [Original Article]
Conclusions—
In older patients with heart failure receiving cardiac resynchronization therapy with defibrillator, diabetes mellitus was independently associated with greater risks of death and rehospitalization, but similar risks of procedural complications.
Source: Circulation: Arrhythmia and Electrophysiology - Category: Cardiology Authors: Echouffo-Tcheugui, J. B., Masoudi, F. A., Bao, H., Spatz, E. S., Fonarow, G. C. Tags: Catheter Ablation and Implantable Cardioverter-Defibrillator, Diabetes, Type 2, Heart Failure, Mortality/Survival, Quality and Outcomes Original Article Source Type: research
More News: Arrhythmia | Cardiac Resynchronization Therapy | Cardiology | Cardiomyopathy | Cardiovascular | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Heart | Heart Failure | Renal Failure